Strongbridge Biopharma plc to Present at the Stifel 2017 Healthcare Conference

DUBLIN, Ireland and TREVOSE, Pa., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that management will present at the Stifel 2017 Healthcare Conference, taking place November 14-15 at the Lotte New York Palace Hotel.